Impact of Culture-Independent Diagnostic Testing on Recovery of Enteric Bacterial Infections

Aamer Imdad1, Fiona Retzer2, Linda S Thomas2

  • 1D. Brent Polk Division of Pediatric Gastroenterology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.

Abstract

Insights

Culture-independent diagnostic tests (CIDTs) show lower pathogen recovery for enteric bacteria. This impacts foodborne illness surveillance, outbreak detection, and public health costs.

Area of Science:

  • Foodborne illness surveillance
  • Public health laboratory diagnostics
  • Molecular subtyping

Background:

  • Culture-independent diagnostic tests (CIDTs) are increasingly utilized for enteric pathogen identification.
  • Traditional foodborne illness surveillance relies on culture confirmation for disease burden estimation and outbreak detection.
  • This study evaluated the impact of CIDTs on pathogen recovery and culture verification costs for key enteric bacteria at a public health laboratory.

Purpose of the Study:

  • To assess the pathogen recovery rates from specimens initially tested by CIDTs compared to culture-based methods.
  • To estimate the associated costs of culture verification for Shigella, Salmonella, Shiga toxin-producing Escherichia coli (STEC), and Campylobacter.
  • To understand the implications of CIDT use on public health surveillance systems.

Main Methods:

  • An observational study utilizing laboratory and epidemiological data from 2013-2016.
  • Calculation of pathogen recovery rates based on initial diagnostic test type (CIDT vs. culture).
  • Modified Poisson regression used to estimate prevalence ratios; cost analysis compared CIDT-positive specimen recovery to culture-derived isolates.

Main Results:

  • Pathogen recovery was significantly lower from CIDT-positive specimens (57%) compared to culture-derived isolates (95%).
  • Recovery rates varied by pathogen: Salmonella (72%), Shigella (64%), STEC (57%), and Campylobacter (26%) from CIDT-positive specimens.
  • Culture verification costs for 100 CIDT-positive specimens were higher for Shigella, Salmonella, and STEC compared to culture-derived isolates.

Conclusions:

  • Low pathogen recovery from CIDT-positive specimens poses challenges for enteric disease surveillance.
  • Current surveillance systems may underestimate disease burden and impact outbreak detection capabilities.
  • The findings highlight significant cost implications for public health programs relying on culture verification.

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.7K
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
368
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
580
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
343
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
545
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
288